Specialized Proresolving Mediators Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Reinfection
暂无分享,去创建一个
[1] R. Furth,et al. Characteristics and Functional Capacities of Human Cord Blood Granulocytes and Monocytes , 1984, Pediatric Research.
[2] Ruth R. Montgomery,et al. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. , 2012, Immunity.
[3] L. Norling,et al. The resolution of inflammation: Principles and challenges. , 2015, Seminars in immunology.
[4] W. Elias,et al. Diarrheagenic Escherichia coli , 2016, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[5] C. Baker,et al. Role of neutrophil receptors in opsonophagocytosis of coagulase-negative staphylococci , 1991, Infection and immunity.
[6] H. Abele,et al. Phagocytosis and postphagocytic reaction of cord blood and adult blood monocyte after infection with green fluorescent protein‐labeled Escherichia coli and group B Streptococci , 2009, Cytometry. Part B, Clinical cytometry.
[7] F. Bussière,et al. Cryptosporidium parvum increases intestinal permeability through interaction with epithelial cells and IL‐1β and TNFα released by inflammatory monocytes , 2016, Cellular microbiology.
[8] B. Finlay,et al. Combating enteropathogenic Escherichia coli (EPEC) infections: the way forward. , 2013, Trends in microbiology.
[9] A. Davies,et al. Minireview: clinical cryptosporidiosis. , 2010, Experimental parasitology.
[10] L. Maródi. Innate cellular immune responses in newborns. , 2006, Clinical immunology.
[11] M. Hersberger,et al. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation , 2013, Lipids in Health and Disease.
[12] D. Borenshtein,et al. Utility of the Citrobacter rodentium infection model in laboratory mice , 2008, Current opinion in gastroenterology.
[13] C. Poets,et al. A new method to quantify phagocytosis and intracellular degradation using green fluorescent protein‐labeled Escherichia coli: Comparison of cord blood macrophages and peripheral blood macrophages of healthy adults , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[14] T. Schmidt,et al. Neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens , 2017, Science.
[15] P. Sansonetti,et al. Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis , 1994, The Journal of experimental medicine.
[16] C. Serhan,et al. Human Milk Proresolving Mediators Stimulate Resolution of Acute Inflammation , 2015, Mucosal Immunology.
[17] L. Bry,et al. THE ROLE OF SPECIFIC IgG AND COMPLEMENT IN COMBATING A PRIMARY MUCOSAL INFECTION OF THE GUT EPITHELIUM. , 2011, European journal of microbiology & immunology.
[18] S. Ygberg,et al. The developing immune system – from foetus to toddler , 2012, Acta paediatrica.
[19] J. Filep,et al. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation , 2012, Proceedings of the National Academy of Sciences.
[20] X. de la Rosa,et al. Novel Resolvin D2 Receptor Axis in Infectious Inflammation , 2017, The Journal of Immunology.
[21] C. Serhan,et al. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. , 2015, Seminars in immunology.
[22] E. De Gregorio,et al. MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life , 2015, The Journal of Immunology.
[23] Gabriel Núñez,et al. Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.
[24] J. Takeda,et al. The Anti-Inflammatory and Proresolving Mediator Resolvin E1 Protects Mice from Bacterial Pneumonia and Acute Lung Injury , 2009, The Journal of Immunology.
[25] C. Siegrist,et al. B-cell responses to vaccination at the extremes of age , 2009, Nature Reviews Immunology.
[26] G. Shan,et al. Etiology of Childhood Infectious Diarrhea in a Developed Region of China: Compared to Childhood Diarrhea in a Developing Region and Adult Diarrhea in a Developed Region , 2015, PloS one.
[27] Derek W. Gilroy,et al. Resolution of inflammation: a new therapeutic frontier , 2016, Nature Reviews Drug Discovery.
[28] H. Kitazawa,et al. Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus Infection , 2016, Front. Immunol..
[29] F. Bäckhed,et al. Age-Dependent Susceptibility to Enteropathogenic Escherichia coli (EPEC) Infection in Mice , 2016, PLoS pathogens.
[30] M. Gareau,et al. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. , 2012, The Journal of infectious diseases.
[31] D. Gilroy,et al. New insights into the resolution of inflammation. , 2015, Seminars in immunology.
[32] M. Pichichero,et al. Immune responses in neonates , 2014, Expert review of clinical immunology.
[33] B. Finlay,et al. Clearance of Citrobacter rodentium Requires B Cells but Not Secretory Immunoglobulin A (IgA) or IgM Antibodies , 2004, Infection and Immunity.
[34] J. Blanco,et al. Virulence Markers of Enteroaggregative Escherichia coli Isolated from Children and Adults with Diarrhea in Brasília, Brazil , 2003, Journal of Clinical Microbiology.
[35] Naveen Surendran,et al. Neonatal Vaccination: Challenges and Intervention Strategies , 2016, Neonatology.
[36] K. Schesser,et al. Murine Neonates Are Highly Resistant to Yersinia enterocolitica following Orogastric Exposure , 2007, Infection and Immunity.
[37] T. O'Shea,et al. Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. , 2011, Cytokine.
[38] J. Schwarze,et al. Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology , 2010, Clinical Microbiology Reviews.
[39] Jean-Frederic Colombel,et al. Adherent-invasive Escherichia coli in inflammatory bowel disease , 2007, Gut.
[40] Charles N. Serhan,et al. Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.
[41] E. Mohr,et al. Vaccination in early life: standing up to the challenges. , 2016, Current opinion in immunology.
[42] V. Nizet,et al. Alterations in neonatal neutrophil function attributable to increased immature forms. , 2016, Early human development.
[43] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[44] A. Lapillonne,et al. Infants fed formula with added long chain polyunsaturated fatty acids have reduced incidence of respiratory illnesses and diarrhea during the first year of life , 2014, BMC Pediatrics.
[45] Sheng-hua Wu,et al. Efficacy and safety of 15(R/S)‐methyl‐lipoxin A4 in topical treatment of infantile eczema , 2013, The British journal of dermatology.
[46] C. Serhan,et al. Identification of resolvin D2 receptor mediating resolution of infections and organ protection , 2015, The Journal of experimental medicine.
[47] A. Varvarigou,et al. Phagocytic ability of neutrophils and monocytes in neonates , 2011, BMC pediatrics.
[48] C. Reardon,et al. Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. , 2010, The Journal of infectious diseases.
[49] D. Gilroy,et al. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. , 2014, Immunity.
[50] G. Dougan,et al. Citrobacter rodentium of mice and man , 2005, Cellular microbiology.
[51] A. Chang,et al. Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? , 2016, Chest.
[52] Inacio Mandomando,et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.
[53] B. Levy,et al. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation , 2015, Nature Reviews Immunology.
[54] C. Serhan,et al. Novel proresolving and tissue‐regenerative resolvin and protectin sulfido‐conjugated pathways , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] G. Núñez,et al. Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination. , 2015, Cell host & microbe.
[56] C. Serhan,et al. Resolvin D3 multi-level proresolving actions are host protective during infection. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.
[57] K. Kim. Acute bacterial meningitis in infants and children. , 2010, The Lancet. Infectious diseases.
[58] M. Perretti,et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis , 2009, Nature.
[59] L. Bry,et al. Critical Role of T Cell-Dependent Serum Antibody, but Not the Gut-Associated Lymphoid Tissue, for Surviving Acute Mucosal Infection with Citrobacter rodentium, an Attaching and Effacing Pathogen 1 , 2004, The Journal of Immunology.
[60] R. F. Ramig. The effects of host age, virus dose, and virus strain on heterologous rotavirus infection of suckling mice. , 1988, Microbial pathogenesis.
[61] C. Serhan,et al. Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance , 2016, Scientific Reports.
[62] S. Savkovic,et al. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation , 2003, Gut.
[63] B. Levy,et al. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation , 2015, Mucosal Immunology.
[64] B. Finlay,et al. Citrobacter rodentium: infection, inflammation and the microbiota , 2014, Nature Reviews Microbiology.
[65] C. Jenkins,et al. An update on the microbiology and epidemiology of enteropathogenic Escherichia coli in England 2010-2012. , 2013, Journal of medical microbiology.
[66] B. Spur,et al. Lipoxin A4 Increases Survival by Decreasing Systemic Inflammation and Bacterial Load in Sepsis , 2011, Shock.
[67] C. Combescure,et al. Environmental and T Cell–Intrinsic Factors Limit the Expansion of Neonatal Follicular T Helper Cells but May Be Circumvented by Specific Adjuvants , 2012, The Journal of Immunology.
[68] M. Mathan,et al. Morphology of rectal mucosa of patients with shigellosis. , 1991, Reviews of infectious diseases.
[69] O. Ramilo,et al. Challenges in infant immunity: implications for responses to infection and vaccines , 2011, Nature Immunology.
[70] K. Schesser,et al. Murine Neonates Infected with Yersinia enterocolitica Develop Rapid and Robust Proinflammatory Responses in Intestinal Lymphoid Tissues , 2013, Infection and Immunity.